Cognizant Trims Top Of 2026 Growth Outlook To 4.4% As Healthcare And Consumer Clients Hold Back
The IT services firm now sees full-year constant-currency growth of 4% to 4.4%, against 4% to 5.5% before, with a softer fourth quarter.
Cognizant, which provides technology and consulting services to business and government clients, cut the top end of its full-year growth guidance to 4.4%, with CFO Jatin Dalal telling analysts on Thursday's earnings call that the range is now 4% to 4.4% in constant currency, from 4% to 5.5% previously. CEO Ravi Kumar said macro uncertainty is weighing on discretionary spending in healthcare and consumer-facing sectors.
Why the range came down
Kumar said conditions were largely stable in the third quarter but that uncertainty is weighing more heavily on discretionary spending in the fourth, particularly in healthcare and consumer-facing sectors. He still argued revenue growth ranks among the top of the company's peer group.
Dalal said the new outlook assumes slightly lower revenue from reselling third-party products and a bigger fourth-quarter hit from client furloughs than previously expected. Financial services and North America's communications, media and technology clients beat expectations, he said, but not by enough to offset softness elsewhere.
Asked by a Guggenheim analyst about the furloughs, Dalal said the company had expected a lighter-than-usual impact because of strong demand from banking and financial clients. It has turned out similar to prior years, he said.
For the fourth quarter, Cognizant expects revenue growth of 3.2% to 4.7% in constant currency, including about 200 basis points (two percentage points) from recent acquisitions.
The 2027 handoff
A Wells Fargo analyst asked whether the fourth-quarter exit rate is a fair proxy for 2027. Dalal said the latest data point is an exit growth rate of 2% and 4% for total and organic growth, and he added that even 2% organic is higher than most large companies' exit 2026 number. The transcript is inconsistent on which of the two figures is organic.
Kumar said the key to unlocking discretionary spend is macro stability, which he sees arriving in 2027 "if everything falls in place." He said financial services, about 37% to 38% of the business, goes into 2027 in good shape, and that healthcare should stabilize as Medicaid and Medicare funding settles.
Dalal said service lines benefiting from AI tailwinds, about 40% of the business, are growing roughly two to three times the rate of total organic services revenue.
Quarter, margins and the stock
Third-quarter revenue rose 4.8% in constant currency to $5.7 billion, and adjusted EPS was $1.49, up 7%. Adjusted operating margin was 16.3%, excluding about $51 million of Project LEAP costs. Full-year margin guidance narrows to about 16.1%.
The company also cut its estimate for total Project LEAP costs to $180 million to $250 million, from $230 million to $320 million, citing lower severance as more staff are retrained and redeployed.
Shares traded at $64.71 in Thursday trading, down 2.49% from the prior close of $66.36, giving the company a market value of $29.9 billion.
Dalal said Cognizant will give 2027 guidance at the start of the year, and that a decision on an India listing will follow draft regulations he expects in a few weeks.
Sources
- Cognizant (CTSH) Beats Q3 Earnings and Revenue Estimates — Yahoo Finance
- Cognizant Technology beats top-line and bottom-line estimates; updates FY26 outlook | Seeking Alpha — seekingalpha.com
- Cognizant: Q3 Earnings Snapshot — Associated Press
- Cognizant: Q3 Earnings Snapshot – WTOP News — wtop.com
- Insights Into Cognizant (CTSH) Q3: Wall Street Projections for Key Metrics — Yahoo Finance